NASDAQ: IMVT · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Immunovant Inc.

How Immunovant Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$6.1B

Price

$29.64

P/E

-11.4

EPS (TTM)

$-2.61

1-year return

36.9%

Dividend yield

0.0%

52-week range

$22.79–$33.78

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources